Al-Dawaa Medical Services Company (TADAWUL:4163)
Saudi Arabia · Delayed Price · Currency is SAR 43.50
-0.44 (-1.00%)
Jul 2, 2026, 3:19 PM AST
TADAWUL:4163 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,617 | 6,736 | 6,454 | 5,741 | 5,372 | 5,034 | |
Revenue Growth (YoY) | 0.34% | 4.37% | 12.42% | 6.87% | 6.71% | 1.46% |
Cost of Revenue | 4,298 | 4,363 | 4,158 | 3,635 | 3,397 | 3,172 |
Gross Profit | 2,318 | 2,373 | 2,296 | 2,107 | 1,975 | 1,863 |
Selling, General & Admin | 1,950 | 1,925 | 1,808 | 1,633 | 1,606 | 1,598 |
Other Operating Expenses | -4.63 | -3.89 | -2.23 | 4.5 | 0.66 | - |
Operating Expenses | 1,948 | 1,924 | 1,806 | 1,638 | 1,607 | 1,598 |
Operating Income | 370.13 | 449.14 | 490.62 | 468.92 | 368.54 | 264.37 |
Interest Expense | -116.04 | -114.13 | -113.56 | -118.32 | -52.6 | -13.2 |
Interest & Investment Income | - | - | - | 0.73 | 4.9 | 6.52 |
Earnings From Equity Investments | -5.61 | -3.85 | - | - | - | - |
Currency Exchange Gain (Loss) | -2.18 | -2.18 | -0.28 | -2 | -1.02 | -9.04 |
Other Non Operating Income (Expenses) | - | - | - | - | - | -2.96 |
EBT Excluding Unusual Items | 246.31 | 328.98 | 376.78 | 349.33 | 319.82 | 245.68 |
Gain (Loss) on Sale of Assets | 0.96 | 0.96 | 1.04 | 1.1 | 3.01 | 0.59 |
Asset Writedown | -12.85 | -7.85 | -3.47 | -5.78 | -7.84 | -1.65 |
Other Unusual Items | 8.66 | 8.66 | -0.78 | -4.62 | 2.69 | 1.26 |
Pretax Income | 244.17 | 331.84 | 373.56 | 342.4 | 317.87 | 246.02 |
Income Tax Expense | 5.33 | 10.08 | 22.15 | 13.18 | 12.42 | 6.87 |
Net Income | 238.84 | 321.76 | 351.41 | 329.22 | 305.45 | 239.14 |
Net Income to Common | 238.84 | 321.76 | 351.41 | 329.22 | 305.45 | 239.14 |
Net Income Growth | -33.89% | -8.44% | 6.74% | 7.78% | 27.73% | -2.96% |
Shares Outstanding (Basic) | 85 | 85 | 85 | 85 | 85 | 85 |
Shares Outstanding (Diluted) | 85 | 85 | 85 | 85 | 85 | 85 |
EPS (Basic) | 2.81 | 3.79 | 4.13 | 3.87 | 3.59 | 2.81 |
EPS (Diluted) | 2.81 | 3.79 | 4.13 | 3.87 | 3.59 | 2.81 |
EPS Growth | -33.89% | -8.44% | 6.74% | 7.78% | 27.73% | -2.96% |
Free Cash Flow | 427.03 | 512.18 | 460.21 | 508.97 | 532.99 | 368.04 |
Free Cash Flow Per Share | 5.02 | 6.03 | 5.41 | 5.99 | 6.27 | 4.33 |
Dividend Per Share | 2.520 | 2.520 | 2.515 | 2.500 | 2.500 | 4.130 |
Dividend Growth | - | 0.20% | 0.60% | - | -39.47% | - |
Gross Margin | 35.04% | 35.23% | 35.58% | 36.69% | 36.77% | 37.00% |
Operating Margin | 5.59% | 6.67% | 7.60% | 8.17% | 6.86% | 5.25% |
Profit Margin | 3.61% | 4.78% | 5.45% | 5.73% | 5.69% | 4.75% |
Free Cash Flow Margin | 6.45% | 7.60% | 7.13% | 8.87% | 9.92% | 7.31% |
EBITDA | 556.69 | 634.74 | 654.54 | 625.06 | 520.59 | 415.09 |
EBITDA Margin | 8.41% | 9.42% | 10.14% | 10.89% | 9.69% | 8.24% |
D&A For EBITDA | 186.56 | 185.6 | 163.92 | 156.14 | 152.05 | 150.72 |
EBIT | 370.13 | 449.14 | 490.62 | 468.92 | 368.54 | 264.37 |
EBIT Margin | 5.59% | 6.67% | 7.60% | 8.17% | 6.86% | 5.25% |
Effective Tax Rate | 2.19% | 3.04% | 5.93% | 3.85% | 3.91% | 2.79% |
Advertising Expenses | - | - | - | - | 24.24 | - |